LIVE VIEW · PTGXProtagonist Therapeutics, IncHealthcarePTGX research Sign up to open the full interactive terminal, save boards, and get alerts
PTGX · Live chart
Loading live chart
PTGX · Smart-money compositeas of Aug 14
+23LONGsmart-money positioning
-100 short0+100 long
Insiderno insider cluster in the l...
Congressno congressional trade in t...
13F fundsLONG
Short volumeFINRA short-volume is not c...
1 of 4 families contributing
PTGX · Recent signals
Q2-2026: Beat consensus by 7.8%, EPS $2.29 vs $2.1238 estimateMEDIUMLONGAug 13
Bridgewater Associates, LP new position in PTGXMEDIUMLONGJul 24
Q2-2025: Beat consensus by 6.8% - EPS $-0.55 vs $-0.59 estimateMEDIUMLONGJun 24
Beat consensus by 6.8% - EPS $-0.55 vs $-0.59 estimateMEDIUMLONGMay 27
Q1-2026: Beat consensus by 109.2% - EPS $0.05 vs $-0.5435 estimateMEDIUMLONGMay 27
Q4-2025: Missed consensus by 38.5% - EPS $-0.69 vs $-0.4983 estimateMEDIUMSHORTMay 27
PTGX · Institutional holdersas of 2025Q4
SOROS FUND MANAGEMENT LLC$8.7Mn/a
MILLENNIUM MANAGEMENT LLC$8.5Mn/a
MILLENNIUM MANAGEMENT LLC$1.5M-86.4%
RENAISSANCE TECHNOLOGIES LLC$713Kn/a
CITADEL ADVISORS LLC$559K+3.2%
Bridgewater Associates, LP$556Kn/a
CITADEL ADVISORS LLC$412Kn/a
Live alerts on PTGX
Live alerts on PTGXGet pinged the moment insiders, congress, or 13F funds move on PTGX.Sign up to unlock
Options positioning and dealer gamma
Options positioning and dealer gammaDealer gamma, call and put walls, and expiry pressure for PTGX.Sign up to unlock
Build your own board
Build your own boardEvery ticker, your own layout, saved boards, and alerts in one terminal.Sign up to unlock